Quality assessment of clinical practice guidelines and consensuses for fungal diseases in China from 2023 to 2024: a study based on the AGREEⅡ
Objective To systematically assess the methodological quality of clinical practice guidelines for fungal diseases to provide a reference for the formulation of guidelines/consensuses in the field of fungal diseases in the future. Methods Guidelines and expert consensuses on fungal diseases were sear...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Office of Journal of Guangxi Medical University
2025-06-01
|
| Series: | Guangxi Yike Daxue xuebao |
| Subjects: | |
| Online Access: | https://journal.gxmu.edu.cn/article/doi/10.16190/j.cnki.45-1211/r.2025.03.021 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849421599857442816 |
|---|---|
| author | Xiaopan WANG Mengya SHANG Wenjie FANG Mingwei DU Xinlin ZHU Qi YIN Xiaogang LIU Weihua PAN Yinuo LIU Wanqing LIAO |
| author_facet | Xiaopan WANG Mengya SHANG Wenjie FANG Mingwei DU Xinlin ZHU Qi YIN Xiaogang LIU Weihua PAN Yinuo LIU Wanqing LIAO |
| author_sort | Xiaopan WANG |
| collection | DOAJ |
| description | Objective To systematically assess the methodological quality of clinical practice guidelines for fungal diseases to provide a reference for the formulation of guidelines/consensuses in the field of fungal diseases in the future. Methods Guidelines and expert consensuses on fungal diseases were searched from relevant databases and related websites such as Medline (via PubMed), Embase, China National Knowledge Infrastructure (CNKI), Wanfang Data Knowledge Service Platform, Chinese Biomedical Literature Database, China Clinical Guidelines Library Network, and China Medical Knowledge Base Guidelines Library from January 2023 to December 2024. After two researchers completed the consistency evaluation, the included guidelines and consensuses were evaluated for methodological quality and the results were analyzed using the Appraisal of Guidelines for Research & Evaluation (AGREE) instrumentⅡ, also known as AGREEⅡ. Results Twenty-two guidelines or consensuses were finally included, of which 8 were rated as grade A (recommended for adoption) and 14 were rated as grade B (recommendable after modification). The scoring rates of the six domains evaluated by AGREE Ⅱ were 8.21%±1.52% for Scope and Purpose, 65.53%±0.79% for Stakeholder Involvement, 68.94%±0.23% for Rigour of Development, 80.81%±0.45% for Clarity of Presentation, 6.35%±0.52% for Applicability, and 67.99% ±4.09% for Independence. Failure to document and disclose conflicts of interest among guideline development group members in terms of independence was a significant factor for score deduction.The guidelines/consensuses in 2024 were superior to those in 2023 in terms of rigour (P < 0.05). Conclusion The methodological quality of fungal disease guidelines and expert consensuses regarding participants, rigour, applicability, and independence needs to be further improved, and the guideline development needs to be in strict accordance with AGREEⅡ requirements to clarify conflicts of interest. |
| format | Article |
| id | doaj-art-a3a53844db99426d868a5839b571865f |
| institution | Kabale University |
| issn | 1005-930X |
| language | zho |
| publishDate | 2025-06-01 |
| publisher | Editorial Office of Journal of Guangxi Medical University |
| record_format | Article |
| series | Guangxi Yike Daxue xuebao |
| spelling | doaj-art-a3a53844db99426d868a5839b571865f2025-08-20T03:31:24ZzhoEditorial Office of Journal of Guangxi Medical UniversityGuangxi Yike Daxue xuebao1005-930X2025-06-0142347548210.16190/j.cnki.45-1211/r.2025.03.021gxykdxxb-42-3-475Quality assessment of clinical practice guidelines and consensuses for fungal diseases in China from 2023 to 2024: a study based on the AGREEⅡXiaopan WANG0Mengya SHANG1Wenjie FANG2Mingwei DU3Xinlin ZHU4Qi YIN5Xiaogang LIU6Weihua PAN7Yinuo LIU8Wanqing LIAO9Department of Dermatology, Shanghai Key Laboratory of Molecular Medical Mycology, Changzheng Hospital, Second Naval Medical University, Shanghai 200003, ChinaDepartment of Dermatology, Shanghai Key Laboratory of Molecular Medical Mycology, Changzheng Hospital, Second Naval Medical University, Shanghai 200003, ChinaDepartment of Dermatology, Shanghai Key Laboratory of Molecular Medical Mycology, Changzheng Hospital, Second Naval Medical University, Shanghai 200003, ChinaDepartment of Dermatology, Shanghai Key Laboratory of Molecular Medical Mycology, Changzheng Hospital, Second Naval Medical University, Shanghai 200003, ChinaDepartment of Dermatology, Shanghai Key Laboratory of Molecular Medical Mycology, Changzheng Hospital, Second Naval Medical University, Shanghai 200003, ChinaDepartment of Dermatology, Shanghai Key Laboratory of Molecular Medical Mycology, Changzheng Hospital, Second Naval Medical University, Shanghai 200003, ChinaDepartment of Dermatology, Shanghai Key Laboratory of Molecular Medical Mycology, Changzheng Hospital, Second Naval Medical University, Shanghai 200003, ChinaDepartment of Dermatology, Shanghai Key Laboratory of Molecular Medical Mycology, Changzheng Hospital, Second Naval Medical University, Shanghai 200003, ChinaDepartment of Dermatology, Shanghai Key Laboratory of Molecular Medical Mycology, Changzheng Hospital, Second Naval Medical University, Shanghai 200003, ChinaDepartment of Dermatology, Shanghai Key Laboratory of Molecular Medical Mycology, Changzheng Hospital, Second Naval Medical University, Shanghai 200003, ChinaObjective To systematically assess the methodological quality of clinical practice guidelines for fungal diseases to provide a reference for the formulation of guidelines/consensuses in the field of fungal diseases in the future. Methods Guidelines and expert consensuses on fungal diseases were searched from relevant databases and related websites such as Medline (via PubMed), Embase, China National Knowledge Infrastructure (CNKI), Wanfang Data Knowledge Service Platform, Chinese Biomedical Literature Database, China Clinical Guidelines Library Network, and China Medical Knowledge Base Guidelines Library from January 2023 to December 2024. After two researchers completed the consistency evaluation, the included guidelines and consensuses were evaluated for methodological quality and the results were analyzed using the Appraisal of Guidelines for Research & Evaluation (AGREE) instrumentⅡ, also known as AGREEⅡ. Results Twenty-two guidelines or consensuses were finally included, of which 8 were rated as grade A (recommended for adoption) and 14 were rated as grade B (recommendable after modification). The scoring rates of the six domains evaluated by AGREE Ⅱ were 8.21%±1.52% for Scope and Purpose, 65.53%±0.79% for Stakeholder Involvement, 68.94%±0.23% for Rigour of Development, 80.81%±0.45% for Clarity of Presentation, 6.35%±0.52% for Applicability, and 67.99% ±4.09% for Independence. Failure to document and disclose conflicts of interest among guideline development group members in terms of independence was a significant factor for score deduction.The guidelines/consensuses in 2024 were superior to those in 2023 in terms of rigour (P < 0.05). Conclusion The methodological quality of fungal disease guidelines and expert consensuses regarding participants, rigour, applicability, and independence needs to be further improved, and the guideline development needs to be in strict accordance with AGREEⅡ requirements to clarify conflicts of interest.https://journal.gxmu.edu.cn/article/doi/10.16190/j.cnki.45-1211/r.2025.03.021fungal diseasesclinical practice guidelinesexpert consensusesthe appraisal of guidelines for research & evaluation instrumentⅱmethodological quality assessment |
| spellingShingle | Xiaopan WANG Mengya SHANG Wenjie FANG Mingwei DU Xinlin ZHU Qi YIN Xiaogang LIU Weihua PAN Yinuo LIU Wanqing LIAO Quality assessment of clinical practice guidelines and consensuses for fungal diseases in China from 2023 to 2024: a study based on the AGREEⅡ Guangxi Yike Daxue xuebao fungal diseases clinical practice guidelines expert consensuses the appraisal of guidelines for research & evaluation instrumentⅱ methodological quality assessment |
| title | Quality assessment of clinical practice guidelines and consensuses for fungal diseases in China from 2023 to 2024: a study based on the AGREEⅡ |
| title_full | Quality assessment of clinical practice guidelines and consensuses for fungal diseases in China from 2023 to 2024: a study based on the AGREEⅡ |
| title_fullStr | Quality assessment of clinical practice guidelines and consensuses for fungal diseases in China from 2023 to 2024: a study based on the AGREEⅡ |
| title_full_unstemmed | Quality assessment of clinical practice guidelines and consensuses for fungal diseases in China from 2023 to 2024: a study based on the AGREEⅡ |
| title_short | Quality assessment of clinical practice guidelines and consensuses for fungal diseases in China from 2023 to 2024: a study based on the AGREEⅡ |
| title_sort | quality assessment of clinical practice guidelines and consensuses for fungal diseases in china from 2023 to 2024 a study based on the agreeii |
| topic | fungal diseases clinical practice guidelines expert consensuses the appraisal of guidelines for research & evaluation instrumentⅱ methodological quality assessment |
| url | https://journal.gxmu.edu.cn/article/doi/10.16190/j.cnki.45-1211/r.2025.03.021 |
| work_keys_str_mv | AT xiaopanwang qualityassessmentofclinicalpracticeguidelinesandconsensusesforfungaldiseasesinchinafrom2023to2024astudybasedontheagreeii AT mengyashang qualityassessmentofclinicalpracticeguidelinesandconsensusesforfungaldiseasesinchinafrom2023to2024astudybasedontheagreeii AT wenjiefang qualityassessmentofclinicalpracticeguidelinesandconsensusesforfungaldiseasesinchinafrom2023to2024astudybasedontheagreeii AT mingweidu qualityassessmentofclinicalpracticeguidelinesandconsensusesforfungaldiseasesinchinafrom2023to2024astudybasedontheagreeii AT xinlinzhu qualityassessmentofclinicalpracticeguidelinesandconsensusesforfungaldiseasesinchinafrom2023to2024astudybasedontheagreeii AT qiyin qualityassessmentofclinicalpracticeguidelinesandconsensusesforfungaldiseasesinchinafrom2023to2024astudybasedontheagreeii AT xiaogangliu qualityassessmentofclinicalpracticeguidelinesandconsensusesforfungaldiseasesinchinafrom2023to2024astudybasedontheagreeii AT weihuapan qualityassessmentofclinicalpracticeguidelinesandconsensusesforfungaldiseasesinchinafrom2023to2024astudybasedontheagreeii AT yinuoliu qualityassessmentofclinicalpracticeguidelinesandconsensusesforfungaldiseasesinchinafrom2023to2024astudybasedontheagreeii AT wanqingliao qualityassessmentofclinicalpracticeguidelinesandconsensusesforfungaldiseasesinchinafrom2023to2024astudybasedontheagreeii |